×
About 68,030 results

ALLMedicine™ Osteoporosis Center

Research & Reviews  32,435 results

Identification of potential specific biomarkers and key signaling pathways between oste...
https://doi.org/10.1186/s13018-020-01965-3
Journal of Orthopaedic Surgery and Research; Wu J, Cai P et. al.

Sep 24th, 2020 - The differentiation of bone mesenchymal stem cells (BMSCs) into adipogenesis (AD) rather than osteogenesis (OS) is an important pathological feature of osteoporosis. Illuminating the detailed mechanisms of the differentiation of BMSCs into OS and ...

Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women wi...
https://doi.org/10.1080/03007995.2020.1824897
Current Medical Research and Opinion; Miller PD, Bilezikian JP et. al.

Sep 24th, 2020 - Objective: Fractures due to osteoporosis represent a serious burden on patients and healthcare systems. The objective of this review is to provide an overview of the anabolic agent abaloparatide (ABL) for the treatment of postmenopausal women with...

Detecting causal relationship between metabolic traits and osteoporosis using multivari...
https://doi.org/10.1007/s00198-020-05640-5
Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA; Zhang Q, Greenbaum J et. al.

Sep 24th, 2020 - By adopting the extension approaches of Mendelian randomization, we successfully detected and prioritized the potential causal risk factors for BMD traits, which might provide us novel insights for treatment and intervention into bone-related comp...

The Role of Novel Bone Forming Agents in the Treatment of Osteoporosis.
https://doi.org/10.1177/0897190020961227
Journal of Pharmacy Practice; Patel HB, Lyerly LJ et. al.

Sep 24th, 2020 - Osteoporosis is a growing epidemic that leads to significant morbidity and mortality among the elderly population due to associated fractures that lead to disabilities and reduced quality of life. Bisphosphonates are well-established as a first-li...

Pleiotropic genomic variants at 17q21.31 associated with bone mineral density and body ...
https://doi.org/10.1038/s41431-020-00727-3
European Journal of Human Genetics : EJHG; Wei XT, Feng GJ et. al.

Sep 23rd, 2020 - Osteoporosis and obesity are two severe complex diseases threatening public health worldwide. Both diseases are under strong genetic determinants as well as genetically correlated. Aiming to identify pleiotropic genes underlying obesity and osteop...

see more →

Guidelines  191 results

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLI...
https://doi.org/10.4158/GL-2020-0524SUPPL
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; Camacho PM, Petak SM et. al.

May 19th, 2020 - Objective: The development of these guidelines is sponsored by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols ...

AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS/AMERICAN COLLEGE OF ENDOCRINOLOGY CLI...
https://doi.org/10.4158/GL-2020-0524
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists; Camacho PM, Petak SM et. al.

May 19th, 2020 - Objective: The development of these guidelines is sponsored by the American Association of Clinical Endocrinologists (AACE) Board of Directors and American College of Endocrinology (ACE) Board of Trustees and adheres with published AACE protocols ...

Osteoporosis Management in the Era of COVID-19.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273005
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research; Yu EW, Tsourdi E et. al.

May 14th, 2020 - Osteoporosis is a chronic condition that reflects reduced bone strength and an associated increased risk for fracture. As a chronic condition, osteoporosis generally requires sustained medical intervention(s) to limit the risks for additional bone...

Diabetes Is Associated with Musculoskeletal Pain, Osteoarthritis, Osteoporosis, and Rheumatoid Arthritis
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6925775/
Journal of Diabetes Research; Rehling T

Dec 5th, 2019 - To investigate the associations between diabetes and musculoskeletal pain, osteoarthritis, osteoporosis, and rheumatoid arthritis.

Management of Osteoporosis in Survivors of Adult Cancers With Nonmetastatic Disease: AS...
https://doi.org/10.1200/JCO.19.01696
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology; Shapiro CL, Van Poznak C et. al.

Sep 18th, 2019 - The aim of this work is to provide evidence-based guidance on the management of osteoporosis in survivors of adult cancer. ASCO convened a multidisciplinary Expert Panel to develop guideline recommendations based on a systematic review of the lite...

see more →

Drugs  381 results see all →

Clinicaltrials.gov  33,333 results

Identification of potential specific biomarkers and key signaling pathways between oste...
https://doi.org/10.1186/s13018-020-01965-3
Journal of Orthopaedic Surgery and Research; Wu J, Cai P et. al.

Sep 24th, 2020 - The differentiation of bone mesenchymal stem cells (BMSCs) into adipogenesis (AD) rather than osteogenesis (OS) is an important pathological feature of osteoporosis. Illuminating the detailed mechanisms of the differentiation of BMSCs into OS and ...

Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women wi...
https://doi.org/10.1080/03007995.2020.1824897
Current Medical Research and Opinion; Miller PD, Bilezikian JP et. al.

Sep 24th, 2020 - Objective: Fractures due to osteoporosis represent a serious burden on patients and healthcare systems. The objective of this review is to provide an overview of the anabolic agent abaloparatide (ABL) for the treatment of postmenopausal women with...

Detecting causal relationship between metabolic traits and osteoporosis using multivari...
https://doi.org/10.1007/s00198-020-05640-5
Osteoporosis International : a Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA; Zhang Q, Greenbaum J et. al.

Sep 24th, 2020 - By adopting the extension approaches of Mendelian randomization, we successfully detected and prioritized the potential causal risk factors for BMD traits, which might provide us novel insights for treatment and intervention into bone-related comp...

The Role of Novel Bone Forming Agents in the Treatment of Osteoporosis.
https://doi.org/10.1177/0897190020961227
Journal of Pharmacy Practice; Patel HB, Lyerly LJ et. al.

Sep 24th, 2020 - Osteoporosis is a growing epidemic that leads to significant morbidity and mortality among the elderly population due to associated fractures that lead to disabilities and reduced quality of life. Bisphosphonates are well-established as a first-li...

Pleiotropic genomic variants at 17q21.31 associated with bone mineral density and body ...
https://doi.org/10.1038/s41431-020-00727-3
European Journal of Human Genetics : EJHG; Wei XT, Feng GJ et. al.

Sep 23rd, 2020 - Osteoporosis and obesity are two severe complex diseases threatening public health worldwide. Both diseases are under strong genetic determinants as well as genetically correlated. Aiming to identify pleiotropic genes underlying obesity and osteop...

see more →

News  1,573 results

Study sees 'probable' higher heart risk for new Amgen osteoporosis drug
https://www.reuters.com/article/us-amgen-osteoporosis/study-sees-probable-higher-heart-risk-for-new-amgen-osteoporosis-drug-idUSKBN23V2US

Jun 24th, 2020 - (Reuters) - An observational study of Amgen Inc’s new osteoporosis drug Evenity released on Wednesday appears to confirm the increased risk of serious heart problems detected in clinical trials and included in the medicine’s prescribing informatio...

Younger gynecologic cancer patients at risk for early bone loss
https://www.mdedge.com/obgyn/article/220103/gynecologic-cancer/younger-gynecologic-cancer-patients-risk-early-bone-loss?channel=39313
Neil Osterweil

Apr 2nd, 2020 - Younger women treated for uterine or ovarian cancer are at increased risk for decreased bone mineral density and osteoporosis, especially in the first year after diagnosis, and they should be screened for bone changes, investigators advise. This r.

Endocrine Society advises on use of romosozumab for osteoporosis
https://www.mdedge.com/obgyn/article/218079/osteoporosis/endocrine-society-advises-use-romosozumab-osteoporosis/page/0/1?channel=266

Feb 28th, 2020 - Not for all women Giving his opinion, Bart Clarke, MD, of the Mayo Clinic in Rochester, Minnesota, underscored the fact that the Fracture Study in Postmenopausal Women With Osteoporosis (FRAME), again conducted in postmenopausal women, showed no i.

Osteoporosis, fracture risk higher in patients with IBD
https://www.mdedge.com/obgyn/article/217937/gastroenterology/osteoporosis-fracture-risk-higher-patients-ibd/page/0/1?channel=266

Feb 26th, 2020 - Screening for TB Screening to rule out latent tuberculosis (TB) is also important in IBD. “We should be looking at whether they’ve had close contact with active TB or people from endemic areas,” said Long.

Vitamin D supplements in pregnancy boost bone health in offspring
https://www.mdedge.com/obgyn/article/217777/osteoporosis/vitamin-d-supplements-pregnancy-boost-bone-health-offspring?channel=266
Bianca Nogrady

Feb 24th, 2020 - Vitamin D supplementation during pregnancy is associated with higher bone mineral content in the offspring, even up to 6 years after birth, research suggests. copyright Joss/Fotolia.

see more →

Patient Education  117 results see all →